½ÃÀ庸°í¼­
»óǰÄÚµå
1292416

¼¼°èÀÇ Ã·´Ü â»ó °ü¸® ±â¼ú ½ÃÀå

Markets for Advanced Wound Management Technologies

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: BCC Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 248 Pages | ¹è¼Û¾È³» : Áï½Ã¹è¼Û

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ Ã·´Ü â»ó °ü¸® ±â¼ú ½ÃÀå ±Ô¸ð´Â 2022³â 107¾ï ´Þ·¯¿¡¼­ 2023-2028³âÀÇ ¿¹Ãø ±â°£ Áß 6.2%ÀÇ CAGR·Î ÃßÀÌÇϸç, 2028³â¿¡´Â 153¾ï ´Þ·¯ ±Ô¸ð·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ºñ»ý¹°ÇÐÀû ÷´Ü â»ó µå·¹½ÌÀç ºÎ¹®Àº 2022³â 41¾ï ´Þ·¯¿¡¼­ 3.9%ÀÇ CAGR·Î ÃßÀÌÇϸç, 2028³â¿¡´Â 52¾ï ´Þ·¯ ±Ô¸ð·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¶ÇÇÑ Ã¢»ó ¹ÙÀÌ¿À·ÎÁ÷½º/»ýüȰ¼º Àç·á ºÎ¹®Àº 2022³â 21¾ï ´Þ·¯¿¡¼­ 12.2%ÀÇ CAGR·Î ÃßÀÌÇϸç, 2028³â¿¡´Â 41¾ï ´Þ·¯ ±Ô¸ð·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ Ã·´Ü â»ó °ü¸® ±â¼ú ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, ½ÃÀå ¹× ±â¼ú ¹è°æ, ½ÃÀå ¿µÇâ¿äÀÎ ¹× ½ÃÀå ±âȸ ºÐ¼®, ¹ý±ÔÁ¦ ȯ°æ, ½ÃÀå ±Ô¸ðÀÇ ÃßÀÌ¡¤¿¹Ãø, °¢Á¾ ±¸ºÐ¡¤Áö¿ªº° »ó¼¼ ºÐ¼®, °æÀï ±¸µµ, ÁÖ¿ä ±â¾÷ÀÇ °³¿ä µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ¿ä¾à¡¤ÇÏÀ̶óÀÌÆ®

Á¦3Àå ½ÃÀå ¹× ±â¼ú ¹è°æ

  • ¿ÜÇǰè
  • â»ó ºÐ·ù
  • â»ó Ä¡À¯ÀÇ ÇÁ·Î¼¼½º
  • â»ó Ä¡À¯ÀÇ ´Ü°è
  • â»ó Ä¡À¯¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ¿äÀÎ
  • â»ó Ä¡À¯¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÀϹÝÀûÀÎ °Ç°­ ÁöÇ¥
  • â»ó Ä¡À¯ÀÇ ÇÕº´Áõ
  • Porter's Five Forces ºÐ¼®

Á¦4Àå ½ÃÀå ³»¿ª : Á¦Ç°/±â¼ú À¯Çüº°

  • °³¿ä
  • ºñ»ý¹°ÇÐÀû ÷´Ü â»ó µå·¹½ÌÀç
  • â»ó ¹ÙÀÌ¿À·ÎÁ÷½º/»ýüȰ¼º Àç·á
  • ¿ÜºÎ â»ó Ä¡À¯ µð¹ÙÀ̽º
  • À¯Âø ¹æÁö Á¦Ç°¡¤±âŸ ÷´Ü ¼Ò¸ðǰ ±â¼ú
  • â»ó ºÀÇÕ ½Ç¶õÆ® ¹× Á¢ÂøÁ¦

Á¦5Àå ¼¼°èÀÇ ºñ»ý¹°ÇÐÀû ÷´Ü â»ó µå·¹½ÌÀç ½ÃÀå

  • Æû µå·¹½ÌÀç
  • ÇÏÀ̵å·Î°Ö µå·¹½ÌÀç
  • Çʸ§ µå·¹½ÌÀç
  • ¾Ë±ä»ê¿° ¹× °ÖÈ­ ¼¶À¯ µå·¹½ÌÀç
  • ÇÏÀ̵å·ÎÄÝ·ÎÀÌµå µå·¹½ÌÀç
  • °íÈí¼ö¼º µå·¹½ÌÀç
  • ÄÁÅà ·¹ÀÌ¾î µå·¹½ÌÀç
  • ±âŸ ÷´Ü µå·¹½ÌÀç

Á¦6Àå ¼¼°èÀÇ Ã¢»ó ¹ÙÀÌ¿À·ÎÁ÷½º/»ýüȰ¼º Àç·á ½ÃÀå

  • ¼¼Æ÷ ¹× Á¶Á÷ ±â¹Ý Á¦Ç°(CTP)/ÇǺΠ´ëüǰ
  • Àΰ£ ¼¼Æ÷ »ýü°øÇÐ ÀÌ½ÄÆí
  • ÀÌÁ¾ÀÌ½ÄÆí
  • µ¿Á¾ÀÌ½ÄÆí
  • Äݶó°Õ µå·¹½ÌÀç
  • ¼ºÀå¿äÀΡ¤±âŸ »ý¹°ÇÐÀû â»ó °ü¸® Á¦Ç°

Á¦7Àå ¼¼°èÀÇ ¿ÜºÎ â»ó Ä¡À¯ µð¹ÙÀ̽º ½ÃÀå

  • À½¾Ðâ»óÄ¡·á(NPWT) ½Ã½ºÅÛ
  • Àç»ç¿ë °¡´É/±âÁ¸Çü NPWT ½Ã½ºÅÛ
  • ÀÏȸ¿ë(Single-Use) NPWT ½Ã½ºÅÛ
  • »ê¼Ò ¿ä¹ý µð¹ÙÀ̽º
  • ±âŸ
  • â»ó¸é ÀýÁ¦ µð¹ÙÀ̽º
  • ü¿Ü Ãæ°ÝÆÄ Ä¡·á µð¹ÙÀ̽º
  • Àü±â Àڱء¤ÀüÀÚÆÄ Ä¡·á µð¹ÙÀ̽º

Á¦8Àå ¼¼°èÀÇ À¯Âø ¹æÁö Á¦Ç°¡¤±âŸ ÷´Ü ¼Ò¸ðǰ ±â¼ú ½ÃÀå

  • À¯Âø ¹æÁö Á¦Ç°
  • ÷´Ü â»ó ¼¼Á¤(Advanced Debriding)¡¤¼¼Á¤Á¦

Á¦9Àå ¼¼°èÀÇ Ã¢»ó ºÀÇÕ ½Ç¶õÆ® ¹× Á¢ÂøÁ¦ ½ÃÀå

Á¦10Àå ½ÃÀå ³»¿ª : Áö¿ªº°

  • ºÏ¹Ì
  • À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ±âŸ Áö¿ª

Á¦11Àå ½ÃÀå ³»¿ª : ¿ëµµº°

  • ±Þ¼º â»ó
  • ÀϹÝÀûÀÎ ±Þ¼º â»óÀÇ À¯Çü
  • ¸¸¼º â»ó
  • ÀϹÝÀûÀÎ ¸¸¼º â»óÀÇ À¯Çü
  • â»ó Åë°è
  • ¼¼°èÀÇ Ã·´Ü â»ó °ü¸® Á¦Ç° ½ÃÀå : â»ó À¯Çüº°
  • ¼¼°èÀÇ Ã·´Ü ±Þ¼º â»ó °ü¸® Á¦Ç° ½ÃÀå : â»ó À¯Çüº°
  • ¼¼°èÀÇ Ã·´Ü ¸¸¼º â»ó °ü¸® Á¦Ç° ½ÃÀå : â»ó À¯Çüº°
  • ºñ»ý¹°ÇÐÀû ÷´Ü â»ó µå·¹½ÌÀç
  • â»ó ¹ÙÀÌ¿À·ÎÁ÷½º/»ýüȰ¼º Àç·á
  • ¿ÜºÎ â»ó Ä¡À¯ µð¹ÙÀ̽º
  • À¯Âø ¹æÁö Á¦Ç°¡¤±âŸ ÷´Ü ¼Ò¸ðǰ ±â¼ú
  • â»ó ºÀÇÕ ½Ç¶õÆ® ¹× Á¢ÂøÁ¦

Á¦12Àå ½ÃÀå ³»¿ª : ÃÖÁ¾»ç¿ëÀÚº°

  • º´¿ø â»ó ¿Ü·¡ ¼¾ÅÍ
  • ÀÔ¿ø ½Ã¼³/º´¿ø
  • ¿ÀÇǽº ¶Ç´Â Ŭ¸®´Ð
  • ±âŸ

Á¦13Àå ±ÔÁ¦ ±¸Á¶¡¤½ÅÁ¦Ç° °³¹ß

  • FDA ½É»ç ¹× ½ÂÀÎ ÇÁ·Î¼¼½º
  • º¸Ç衤»óȯ
  • ÀÓ»ó °³¹ßÁßÀÎ »õ·Î¿î â»ó Ä¡·á ¹ÙÀÌ¿À·ÎÁ÷½º
  • Á¦Ç°
  • ¿ëµµ

Á¦14Àå »õ·Î¿î °³¹ß°ú ½Å±Ô ±â¼ú

  • °³¹ßÁßÀΠ÷´Ü â»ó °ü¸® Á¦Ç°
  • Àΰ£ ÅÂ¹Ý Á¦´ë Á¶Á÷
  • Àü±â ÀÚ±Ø Ç÷§Æû
  • Àú¼±·® Á¶Á÷ »ê¼ÒÈ­ ½Ã½ºÅÛ
  • ´ëü ÇǺÎ
  • Áٱ⼼Æ÷¸¦ Æ÷ÇÔÇÑ ÇÏÀ̵å·Î°Ö ½ÃÆ®
  • Àΰ£ ¾ç¼ö
  • ¸Þ½Ã ÀÚ°¡ ÀÌ½ÄÆí
  • ¹ÚÅ׸®¿ÀÆÄÁö ¸¶ÀÌÅ©·Îĸ½¶ ½ºÇÁ·¹ÀÌ
  • ÀÚ°¡ ÇǺΠÁٱ⼼Æ÷ ¿ä¹ý

Á¦15Àå °æÀï ±¸µµ

  • °³¿ä
  • ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Á¡À¯À²
  • ÁÖ¿ä ±â¾÷ : Á¦Ç° À¯Çüº°
  • ºñ»ý¹°ÇÐÀû ÷´Ü â»ó µå·¹½ÌÀç
  • â»ó ¹ÙÀÌ¿À·ÎÁ÷½º/»ýüȰ¼º Àç·á
  • ¿ÜºÎ â»ó Ä¡À¯ µð¹ÙÀ̽º
  • â»ó ºÀÇÕ ½Ç¶õÆ® ¹× Á¢ÂøÁ¦
  • ÃÖ±Ù »ê¾÷ Ȱµ¿
  • Á¦Ç° ¹ß¸Å¡¤½ÂÀÎ
  • M&A
  • ±âŸ °³¹ß
  • »ê¾÷ ¸®´õ·ÎºÎÅÍÀÇ ÀλçÀÌÆ®

Á¦16Àå ½ÃÀå ¿ªÇÐ

  • ½ÃÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ

Á¦17Àå COVID-19ÀÇ ¿µÇâ

Á¦18Àå ±â¾÷ °³¿ä

  • 3M
  • ABBVIE INC.
  • ADVANCED MEDICAL SOLUTIONS GROUP PLC
  • BIOTISSUE INC.
  • B. BRAUN MELSUNGEN AG
  • CARDINAL HEALTH
  • COLOPLAST A/S
  • CONVATEC GROUP PLC
  • COOK BIOTECH INC.
  • DERMARITE INDUSTRIES LLC
  • ESSITY
  • INTEGRA LIFESCIENCES HOLDINGS CORP.
  • MEDLINE INDUSTRIES
  • MIMEDX
  • MISONIX INC.
  • MOLNLYCKE HEALTH CARE AB.
  • ORGANOGENESIS HOLDINGS INC.
  • PAUL HARTMANN AG
  • SMITH & NEPHEW PLC
  • URGO GROUP
  • WINNER MEDICAL CO., LTD.

Á¦19Àå ºÎ·Ï : µÎÀÚ¾î

KSA 23.06.26

Highlights:

The global advanced wound management products market reached $10.7 billion in 2022 and should reach $15.3 billion by 2028, with a compound annual growth rate (CAGR) of 6.2% during the forecast period of 2023-2028.

Advanced nonbiological wound dressings segment of the global advanced wound management products market reached $4.1 billion in 2022 and should reach $5.2 billion by 2028, with a CAGR of 3.9% during the forecast period of 2023-2028.

Wound biologics/bioactives segment of the global advanced wound management products market reached $2.1 billion in 2022 and should reach $4.1 billion by 2028, with a CAGR of 12.2% during the forecast period of 2023-2028.

Report Scope:

This report aims to provide a comprehensive study of the global market for AWM products and technologies. It describes the different types of AWM products (advanced nonbiological wound dressings, wound biologics/bioactives, external wound healing devices, anti-adhesion products and other advanced consumable technologies and wound closure sealants and glues) and their current and historical market revenues. Advanced nonbiological wound dressings are categorized in foam, hydrogel, film, alginate and gelling fiber, hydrocolloid, superabsorbent, contact layer, and other advanced nonbiological wound dressings. Wound biologics/bioactives are divided into cellular and tissue-based products (CTPs)/skin substitutes and other biologic therapies. External wound healing devices are segmented into negative pressure wound therapy systems, oxygen therapy devices and other external wound healing devices. The market for anti-adhesion products and other advanced consumable technologies is divided into anti-adhesion products and advanced debriding and cleansing agents.

This report also studies applications for advanced wound management products: acute wounds and chronic wounds. The AWM market for acute wounds includes surgical and traumatic wounds and burns. The AWM market for chronic wounds includes diabetic foot ulcers, pressure ulcers, and venous leg and other ulcers. An in-depth analysis of the global AWM market includes historical data and market projection on sales by product type, application, end user, region, and country-specific market segmentation.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors and their respective market shares. However, this report does not cover support/complementary products that are used to enhance wound healing outcomes, such as compression systems, skin protectants, cover dressings, tapes and wound assessment tools.

Report Includes:

  • 169 data tables and 75 additional tables
  • An up-to-date review and analysis of the global market for advanced wound management (AWM) products and technologies
  • Analyses of the global market trends, with historical market revenue data (sales figures) for 2020 and 2021, estimates for 2022, forecasts for 2023, and projections of compound annual growth rates (CAGRs) through 2028
  • Discussion of industry growth driving factors and major technology issues and challenges affecting the global market for AWM technologies as a basis for projecting demand in the next few years (2023-2028)
  • Estimation of the actual market size and revenue forecast for the global advanced wound management market in USD million values, and corresponding market share analysis based on product type, application, end user, and region
  • Analysis of the market opportunities and future prospects with relate to advanced wound management, applications and business considerations of AWM products and technologies with emphasis on the relevant market forces and macroeconomic factors
  • Review of selected new AWM products in development and emerging technologies, clinical trial applications, and potential markets for future developments
  • Insight into the recent industry structure, competitive aspects of each product segment, increasing investment on R&D activities, market development strategies, and company value share analysis
  • Identification of major stakeholders and analysis of the company competitive landscape based on their recent developments, financial performance, segmental revenues, and operational integration
  • Company profiles of major players within the industry, including 3M, AbbVie Inc., B. Braun Melsungen AG, Cardinal Health, and Smith & Nephew Plc

Table of Contents

Chapter 1 Introduction

  • Study Goals and Objectives
  • Scope of Report
  • What's New in This Report?
  • Methodology and Information Sources
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

  • The Integumentary System
  • Wound Classifications
  • Process of Wound Healing
  • Stages of Wound Healing
  • Inflammatory Phase
  • Destructive Phase
  • Proliferative Phase
  • Maturation
  • Healing by Secondary Intention
  • Factors Affecting Wound Healing
  • General Health Indicators Affecting Wound Healing
  • Complications of Wound Healing
  • Porter's Five Forces Analysis

Chapter 4 Market Breakdown by Product/Technology Type

  • Overview
  • Advanced Nonbiological Wound Dressings
  • Wound Biologics/Bioactives
  • External Wound Healing Devices
  • Anti-Adhesion Products and Other Advanced Consumable Technologies
  • Wound Closure Sealants and Glues
  • Global Market for AWM Products by Type

Chapter 5 Global Market for Advanced Nonbiological Wound Dressings

  • Foam Dressings
  • Hydrogel Dressings
  • Film Dressings
  • Alginate and Gelling Fiber Dressings
  • Hydrocolloid Dressings
  • Superabsorbent Dressings
  • Contact Layer Dressings
  • Other Advanced Dressings
  • Global Market for Advanced Nonbiological Wound Dressings by Product Type

Chapter 6 Global Market for Wound Biologics/Bioactive Dressings

  • Cellular and Tissue-based Products (CTPs)/Skin Substitutes
  • Human Cellular Bioengineered Grafts
  • Xenografts
  • Allografts
  • Collagen Dressings
  • Growth Factors and Other Biologic Wound Management Products
  • Global Market for Wound Biologics/Bioactives by Product Type

Chapter 7 Global Market for External Wound Healing Devices

  • Negative Pressure Wound Therapy Systems
  • Reusable/Traditional NPWT Systems
  • Single-Use NPWT Systems
  • Oxygen Therapy Devices
  • Other External Wound Healing Devices
  • Wound Debridement Devices
  • Extracorporeal Shock Wave Therapy Devices
  • Electrical Stimulation and Electromagnetic Therapy Devices
  • Global Market for External Wound Healing Devices by Product Type

Chapter 8 Global Market for Anti-Adhesion Products and Other Advanced Consumable Technologies

  • Anti-Adhesion Products
  • Advanced Debriding and Cleansing Agents
  • Global Market for Anti-Adhesion Products and Other Advanced Consumable Technologies by Product Type

Chapter 9 Global Market for Wound Closure Sealants and Glues

  • Global Market for Wound Closure Sealants and Glues

Chapter 10 Market Breakdown by Region

  • Global Markets for Advanced Wound Management Products by Region
  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • Rest of Asia-Pacific
  • Rest of the World (RoW)
  • Global Markets for AWM Product Types by Region
  • Advanced Nonbiological Wound Dressings
  • Wound Biologics/Bioactives
  • External Wound Healing Devices
  • Anti-Adhesion Products and Other Advanced Consumable Technologies
  • Wound Closure Sealants and Glues

Chapter 11 Market Breakdown by Application

  • Acute Wounds
  • Common Types of Acute Wounds
  • Chronic Wounds
  • Common Types of Chronic Wounds
  • Wound Statistics
  • Global Market for AWM Product Types by Wound Type
  • Global Market for Advanced Acute Wound Management Products by Wound Type
  • Global Market for Advanced Chronic Wound Management Products by Wound Type
  • Global Market for AWM Product Types by Wound Type
  • Nonbiological Wound Dressings
  • Wound Biologics/Bioactives
  • External Wound Healing Devices
  • Anti-Adhesion and Other Advanced Consumable Technologies
  • Wound Closure Sealants and Glues

Chapter 12 Market Breakdown by End User

  • Hospital Outpatient Wound Centers
  • Inpatient Settings/Hospitals
  • Office or Clinic Settings
  • Others
  • Global Market for Advanced Wound Management Products by End User

Chapter 13 Regulatory Structure, and New Product Developments

  • FDA Regulatory Review and Approval Process Governing Cellular and/or Tissue-Based Products (CTPs) or Skin Substitutes
  • Premarket Approval (PMA)
  • 510(k) Clearance
  • Biologics License Application (BLA)
  • 361 Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps)
  • Humanitarian Device Exemption
  • Coverage and Reimbursement
  • Medicare Coverage
  • Medicaid
  • Private Payers
  • FDA Approvals for Wound Care Biologics, by Approval Type
  • 510 (K) Approvals
  • BLA Approvals
  • New Wound Care Biologics in Clinical Developments
  • Products
  • Applications

Chapter 14 New Developments and Emerging Technologies

  • AWM Products in Development
  • Human Placental Umbilical Cord Tissue
  • Electrical Stimulation Platform
  • Low-Dose Tissue Oxygenation System
  • Skin Substitute
  • Hydrogel Sheet Containing Stem Cells
  • Human Amniotic Liquid
  • Meshed Autograft
  • Bacteriophage-Loaded Microcapsule Spray
  • Autologous Skin Stem Cell Therapy

Chapter 15 Competitive Landscape

  • Overview
  • Global Market Shares of Leading Companies
  • Leading Companies by Product Type
  • Advanced Nonbiological Wound Dressings
  • Wound Biologics/Bioactives
  • External Wound Healing Devices
  • Wound Closure Sealants and Glues
  • Recent Industry Activities
  • Product Launches and Approvals
  • Acquisitions and Mergers
  • Other Developments
  • BCC Research Select Insights from Industry Leaders

Chapter 16 Market Dynamics

  • Market Drivers
  • Favorable Global Demographics and Aging Population
  • Greater Incidence of Obesity, Diabetes and Other Chronic Conditions
  • Increasing Acceptance of Innovative Technologies and Protocols for Complex Wound Treatment
  • Emerging Markets
  • Technology Innovations and New Product Development
  • Market Restraints
  • High Cost of AWM Products
  • Reimbursement and Pricing Issues
  • Stringent Regulatory Environment
  • Market Opportunities
  • Market Consolidation
  • Multiple Underpenetrated Markets Outside the U.S.

Chapter 17 Impact of COVID-19 Pandemic

Chapter 18 Company Profiles

  • 3M
  • ABBVIE INC.
  • ADVANCED MEDICAL SOLUTIONS GROUP PLC
  • BIOTISSUE INC.
  • B. BRAUN MELSUNGEN AG
  • CARDINAL HEALTH
  • COLOPLAST A/S
  • CONVATEC GROUP PLC
  • COOK BIOTECH INC.
  • DERMARITE INDUSTRIES LLC
  • ESSITY
  • INTEGRA LIFESCIENCES HOLDINGS CORP.
  • MEDLINE INDUSTRIES
  • MIMEDX
  • MISONIX INC.
  • MOLNLYCKE HEALTH CARE AB.
  • ORGANOGENESIS HOLDINGS INC.
  • PAUL HARTMANN AG
  • SMITH & NEPHEW PLC
  • URGO GROUP
  • WINNER MEDICAL CO., LTD.

Chapter 19 Appendix: Acronyms

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦